May 11, 2020
New Study Links Obesity to Faster Nerve Loss in People with MS
- /
Click HERE to Subscribe for the MS Beacon Newsletter April 23, 2020 Johns Hopkins University researchers funded in part by…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
May 10, 2020
FDA Approves Bafiertam, (a Tecfidera) Generic, for Relapsing MS
- /
- /
Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis BAFIERTAM™ (monomethyl fumarate), the bioequivalent alternative to Biogen’s…
May 10, 2020
3 Techniques to Help You Overcome Anxiety and Stress
- /
- /
05.05.20 – BY JESSIE ACE – MultipleSclerosisNewsToday Anxiety and stress are unhelpful for anyone’s mind or body, particularly with a chronic illness…
May 9, 2020
Blogger @TrevisGleason muses on mixed messaging around face masks in the time of COVID-19
- /
- /
There have been plenty of mixed messages given about face masks during the COVID-19 pandemic — but masking up could…
May 8, 2020
COVID-19 EMERGENCY FOOD ASSISTANCE
- /
Click: https://teamrubiconusa.org/applynow/ Supported by: Bristol Myers Squibb Foundation ++++++++++++++++++++++++++++++++++++++++++++ Click HERE to Subscribe for the MS Beacon Newsletter ………………………………………………………………………… This article…
May 3, 2020
A Phase 2 Multicenter Study of Ublituximab, a Novel Glycoengineered anti-CD20 Monoclonal Antibody, in Patients With Relapsing Forms of Multiple Sclerosis
- /
Click HERE to Subscribe for the MS Beacon Newsletter 2020 — Background: Ublituximab, a novel monoclonal antibody (mAb) targeting a…
May 1, 2020
Best Life: Robotic exoskeleton helps multiple sclerosis patients walk again
- /
By Ivanhoe Broadcast News | May 1, 2020 at 7:33 AM CDT – Updated May 1 at 7:34 AM Cleveland, Ohio (Ivanhoe Newswire)…
May 1, 2020
Life in the Time of COVID-19 – from New Mobility Magazine (Life beyond wheels)
- /
- /
- /
- /
A trailblazing nurse wheels onto the front lines in New York City; an expectant mother with quadriplegia prepares for the…
May 1, 2020
Ofatumumab (anti-CD20) Displays Superiority to Teriflunomide in Relapsing MS
- /
Ofatumumab, Novartis’s fully human anti-CD20 monoclonal antibody, demonstrated a reduction in the risk of 3- and 6-month confirmed disability progression…
May 1, 2020
Siponimod Shows EDSS Subscale Benefits in Secondary Progressive MS
- /
- /
Novartis’s S1P receptor modulator siponimod (Mayzent) showed benefits in a number of patients with SPMS on the Motor Integration and…
